We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Sterling Infrastructure
STRL
$16.7B
| $3.19M | ﹤0.01% |
304,231
+139,235
| +84% | +$1.29M |
|
|
AIMT
2127
DELISTED
Aimmune Therapeutics
AIMT
| $3.18M | ﹤0.01% |
190,418
+1,841
| +1% | +$31.3K |
|
|
TCDA
2128
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.17M | ﹤0.01% |
115,513
-107,389
| -48% | -$2.93M |
|
|
ATRS
2129
DELISTED
Antares Pharma, Inc.
ATRS
| $3.17M | ﹤0.01% |
1,153,065
+21,616
| +2% | +$60.3K |
|
2130
Levi Strauss
LEVI
$9.39B
| $3.17M | ﹤0.01% |
236,293
-995
| -0.4% | -$13.1K |
|
|
BFYT
2131
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.15M | ﹤0.01% |
153,702
+11,949
| +8% | +$253K |
|
2132
Golar LNG
GLNG
$5.13B
| $3.14M | ﹤0.01% |
425,432
+19,925
| +5% | +$138K |
|
2133
Vanda Pharmaceuticals
VNDA
$302M
| $3.14M | ﹤0.01% |
274,444
-525,247
| -66% | -$5.95M |
|
2134
Oxford Industries
OXM
$552M
| $3.14M | ﹤0.01% |
71,246
+168
| +0.2% | +$6.99K |
|
2135
DHT Holdings
DHT
$3.02B
| $3.12M | ﹤0.01% |
607,938
-229,653
| -27% | -$1.46M |
|
2136
Veeco
VECO
$3.23B
| $3.12M | ﹤0.01% |
231,029
+15,677
| +7% | +$180K |
|
2137
Acco Brands
ACCO
$407M
| $3.11M | ﹤0.01% |
438,199
-8,722
| -2% | -$54.2K |
|
|
RST
2138
DELISTED
ROSETTA STONE INC
RST
| $3.11M | ﹤0.01% |
184,272
+66,801
| +57% | +$1.12M |
|
2139
Abercrombie & Fitch
ANF
$5B
| $3.1M | ﹤0.01% |
291,715
+74,919
| +35% | +$818K |
|
|
TPC
2140
Tutor Perini Cor
TPC
$5.21B
| $3.1M | ﹤0.01% |
310,278
+140,423
| +83% | +$1.26M |
|
|
TEN
2141
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $3.09M | ﹤0.01% |
409,225
+1,493
| +0.4% | +$8.7K |
|
2142
Marcus & Millichap
MMI
$1.19B
| $3.09M | ﹤0.01% |
107,181
+9,869
| +10% | +$278K |
|
|
ALX
2143
Alexander's
ALX
$1.41B
| $3.09M | ﹤0.01% |
9,395
-1,115
| -11% | -$299K |
|
|
AXDX
2144
DELISTED
Accelerate Diagnostics
AXDX
| $3.08M | ﹤0.01% |
20,353
-8,189
| -29% | -$807K |
|
2145
Noodles & Co
NDLS
$107M
| $3.08M | ﹤0.01% |
63,663
+16,137
| +34% | +$685K |
|
|
ACH
2146
Accendra Health
ACH
$214M
| $3.08M | ﹤0.01% |
404,118
+52,548
| +15% | +$385K |
|
2147
German American Bancorp
GABC
$1.9B
| $3.08M | ﹤0.01% |
98,973
+4,340
| +5% | +$125K |
|
2148
Cohu
COHU
$2.5B
| $3.07M | ﹤0.01% |
177,244
+21,321
| +14% | +$329K |
|
|
DVAX
2149
DELISTED
Dynavax Technologies
DVAX
| $3.06M | ﹤0.01% |
345,540
+52,953
| +18% | +$268K |
|
|
SRDX
2150
DELISTED
Surmodics
SRDX
| $3.06M | ﹤0.01% |
70,802
+1,164
| +2% | +$44.1K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.